The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

• Stephanie Hametner,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine IV, Elisabeth Hospital, Linz, Austria

  ⨯
• Arnulf Ferlitsch,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine III, Medical University Vienna, Austria

  ⨯
• Monika Ferlitsch,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine III, Medical University Vienna, Austria

  ⨯
• Alexandra Etschmaier,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine III, Medical University Vienna, Austria

  ⨯
• Rainer Schöfl,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine IV, Elisabeth Hospital, Linz, Austria

  ⨯
• Alexander Ziachehabi,

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine IV, Elisabeth Hospital, Linz, Austria

  ⨯
• Andreas Maieron

  * E-mail: andreas.maieron@elisabethinen.or.at

  Affiliation Department of Gastroenterology and Hepatology, Division of Internal Medicine IV, Elisabeth Hospital, Linz, Austria

  ⨯